Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-08

Clinical Trial Update: Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)

View source ↗

Summary

This document reports a completed safety study evaluating abatacept for treating rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Status: COMPLETED